Other Events ·
Cevian Capital II GP Limited increased its aggregate voting rights in Smith & Nephew plc to 13.206621% as of June 25…
SNNSmith & Nephew PLC
Cevian Capital II GP Limited increased its aggregate voting rights in Smith & Nephew plc to 13.206621% as of June 25, 2026, up from 13.056468%. The increase was driven by Cevian Capital II Master Fund L.P. raising its holding to 12.018425% from 11.868271%, while Cevian Capital II Co-Investment - Series P L.P. remained unchanged at 1.188196%. The total number of voting rights held is 111,788,454. Smith & Nephew plc is a medical technology company that develops and manufactures orthopedic and wound care products.